Terminated PHASE2 INTERVENTIONAL 1-arm NCT01619696

Prospective Pilot Study of Multimodal Radiological Evaluation Feasibility During Chemoradiotherapy of Rectal Adenocarcinomas

Prospective Pilot Study of Multimodal Radiological Evaluation Feasibility During Chemoradiotherapy of Rectal Adenocarcinomas.

Sponsor: Centre National de la Recherche Scientifique, France

Conditions Rectal Adenocarcinoma

Interventions Pelvic MRI and F MISO TEP

Updated 5 times since 2017 Last updated: Jan 22, 2013 Started: Mar 31, 2011 Primary completion: Dec 31, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Insufficient recruitment

Other terminated trials from Centre National de la Recherche Scientifique, France

See all terminations from Centre National de la Recherche Scientifique, France

Other Rectal Adenocarcinoma trials with similar outcome

Browse all Rectal Adenocarcinoma trials

Listed as NCT01619696, this PHASE2 trial focuses on Rectal Adenocarcinoma and remains terminated or withdrawn. Sponsored by Centre National de la Recherche Scientifique, France, it has been updated 5 times since 2011, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE2

First recorded

Mar 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre National de la Recherche Scientifique, France
Institut National de la Santé Et de la Recherche Médicale, France
University Hospital, Toulouse

Data source: University Hospital, Toulouse

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toulouse, France